CytoImmune Therapeutics
PrivateLast Round
Series A
Aug 6, 2021
Total Funding Raised
$36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CytoImmune Therapeutics is a clinical-stage biotechnology company that develops engineered natural killer (NK) cell-based cancer immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoImmune Therapeutics Comparables
Compare CytoImmune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ONK Therapeutics | 87% | |
| Shoreline Biosciences | 86% | |
| Artiva | 78% |
CytoImmune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 6, 2021 |
Key People
Founding team and executive leadership
CytoImmune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofinnova Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 89% MoM.
- Apr 4, 2026
Monthly visitors increased 832% MoM.
CytoImmune Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CytoImmune Therapeutics's valuation, stock price, and market status.
Is CytoImmune Therapeutics a public or private company?
CytoImmune Therapeutics is a private company.
What is the current stock price of CytoImmune Therapeutics?
CytoImmune Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is CytoImmune Therapeutics worth (valuation)?
Valuation information for CytoImmune Therapeutics is not publicly available.
Can I buy CytoImmune Therapeutics stock?
CytoImmune Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CytoImmune Therapeutics's last funding round?
CytoImmune Therapeutics's most recent funding round was Series A on August 6, 2021.
Who are the main investors in CytoImmune Therapeutics?
Key investors in CytoImmune Therapeutics include Sofinnova Partners.
Will CytoImmune Therapeutics IPO soon?
No public IPO plans have been announced for CytoImmune Therapeutics.
How can I track CytoImmune Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CytoImmune Therapeutics's secondary market activity and sign up for updates.